The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

But 25-year-old Madison Burgess has thrown caution to the wind by opting to micro-dose the drug. The Michigan native revealed ...

From lemon coffee to oatzempic, there's always a new weight loss hack people are buzzing about. The latest of these is ricezempic. It's a limey drink of rice water, and hundreds of TikTok users are ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

PepsiCo (PEP) is a 'Strong Buy' with robust profitability, strategic growth, and decade-low valuation. Read an investment ...

Sky-high demand, a high price tag and tight supplies have created opportunities for bad actors to take advantage of consumers ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...